GlassScriptPhysician profile
Raul C Marquez
NPI 1356315287
$2,116.48
in general payments reported to CMS, 2019-2025
17 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $74.22 · 2021: $222 · 2022: $780 · 2023: $318 · 2024: $68.58 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $400.00 | 2022 | |
| Haemonetics Corporation | $369.05 | 2021-2023 | Teg6s Hemostasis System |
| Abiomed | $298.61 | 2020-2025 | Impella |
| Edwards Lifesciences Corporation | $289.17 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $150.34 | 2019-2020 | |
| Abbott Laboratories | $131.77 | 2022 | |
| Covidien LP | $129.71 | 2019 | |
| Baxter Healthcare | $98.06 | 2022 | |
| Medtronic Vascular, INC. | $84.30 | 2019 | |
| Amgen INC. | $27.30 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $27.02 | 2025 | Bridion |
| Medtronic, INC. | $26.75 | 2023 | Avalus |
| Glaxosmithkline, LLC. | $23.79 | 2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $16.53 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.31 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $15.06 | 2019 | |
| Chiesi USA, INC. | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Marquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.